Ignite Creation Date:
2024-07-17 @ 11:09 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466018
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-11-29
Brief Title:
Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation Biocor Cohort
Sponsor:
Clinact
Organization:
Clinact
Study Overview
Official Title:
Recherche de Biomarqueurs moléculaires et dImagerie Diagnostiques et Pronostiques Des Atteintes Oculaires associées à Des dérégulations Neurovasculaires Cohorte Biocor
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BIOCOR
Brief Summary:
BIOCOR is an interventional clinical trial whose main objectives are Objectif are identify molecular biomarkers of ocular rosacea and pachychoroid Endpoints are Correlation between pachychoroidosis defined by choroidal phenotype parameters in OCT and autofluorescence or the stage of ocular rosacea ROSCO29 definition and biological markers selected on the basis of preclinical work animal model and by unbiased methods proteomics metabolomics meibum lipidomics The study of circulating ocular and functional biomarkers would enable us to confirm our hypothesis and identify patients who could benefit from treatments that regulate the ANS andor mineralocorticoid pathways
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None